Use of standards: can we really be analysis ready?
|
|
- Lynette Hutchinson
- 8 years ago
- Views:
Transcription
1 Standards in analysis & reporting Use of standards: can we really be analysis ready?
2 Analysis ready? Why? Reducing time to market/approval Reducing time to delivery Reducing re work Designing subsequent studies deliver reproducible results Responding to regulatory queries What? Analysis of clinical trial studies for CSR Post text TLFs In text tables / figures Case Report Tabulation Support for monitoring boards/committees Analysis of multiple l studies (ISS/E, SCS/E) Exploratory analysis How? Standardize
3 Standardization What can we do? Process Approach to analysis of end points Including safety end points Develop detailed analysis plans Including Master/Project analysis plans Develop standard analyses Wherever possible (across all domains/modules) Completion of programmingduring study conduct Identify which subject/visits are clean Identification of potential changes towards DBL Perform planned testing of programs Perform planned testing of programs Identifying what requires change from planned analysis Plan for it
4 CROSS FUNCTIONAL SYNERGIES
5 Data Management Draft protocol Development Synergies at Study Setup process Ethics Committee Meeting CRF build Draft Data Management Plan Data Extraction Database Build Data Management Plan FSI SAP developed conjointly, immediately after finalisation of study protocol & CRF Reviews and inputs received from the MW and Regulatory teams Stats / Programming Draft SAP SAP including detailed programming specifications Medical Writing Review Skeleton TLGs Clinical teams Review Skeleton TLGs Regulatory / Clinical teams providing feedback on TLGs Abbreviations: SAP: Statistical Analysis Plan; TLG: Tables Listings & Graphs
6 Synergies at Study conduct Data Management Stats / rogramming Early review of draft TLGs FSI 25% 50% 95% MW& Regulatory review of TLGs Additional Analysis determination & SAP updation CSR Skeleton finalization Data Management Recommendation on anyadditional additional checks based on Data review Start Programming Draft TLGs LSLV Database Lock activities Clean File DBL Final Data Extraction Unblind P Additional Analysis Draft TLGs M edical Writing Skeleton CSR Clinical Teams Request for additional data based on other study results results of the current study Review TLGs Review Skeleton CSR BDRs as per project plan Abbreviations: TLG: Tables Listings & Graphs; CSR: Clinical Study Report; BDR: Blinded Data Review
7 Synergies at Study Closure DBL Parallel Processing of CSR, along with the Final TLG preparation CSR Finalization Study Closure Data a Managem ment Stats / Program mming Final Data Extraction Unblind Key results published Other reports published Final TLGs prepared Creation of ectd format (if required) Medical Writing / Publishing Draft CSR Draft CSR review Final CSR preparation Collation Collation of of appendix appendix items items for for CSR CSR Additional Analysis reports Finalization of CSR Client teams Review Final BDRs Stats Review Review MW deliverables CSR Publishing Signoff on Final CSR Abbreviations: TLG: Tables Listings & Graphs; CSR: Clinical Study Report; BDR: Blinded Data Review
8 Data Standards Data collection instruments Standardize CRFs CDASH Data Transformation CDISC SDTM ADaM SDTM as part of the process rather than submission TLFs Standardize At various levels At various levels 1) Organization 2) TA/DA 3) Project
9 Recommended Methodologies for Creating Data Collection Instruments CDASH Methodology Necessary Data Only CRFs should avoid collecting redundant should instead focus on collecting needed ddto answer the protocol questions provide adequate safety data. Rationale Usually, only data that will be used for analysis should be collected on the CRF due to the cost and time associated itdwith collecting data. dt Data that is collected should generally be reviewed and cleaned. When available, the Statistical Analysis Plan (SAP) needs to be reviewed to ensure that the parameters needed for analysis are collected and can be easilyanalyzed. The Statistician is responsible for confirming that the CRF collects all of the correct data.
10 Recommended Methodologies for Creating Data Collection Instruments CDASH Methodology Adequate Review The team that designs the data collection instruments for a study needs to be involved din the development of the protocol and should have appropriate expertise represented on the CRF design team (e.g., statistics, programming, datamanagement, clinical operations, science,regulatory, pharmacovigilance). Statisticians should review the CRF against their planned analyses to make sure all required data will be collected in an appropriate form for those analyses. Rationale The CRF design team should perform an adequate review of the CRF to ensure that the CRF captures all of the data needed ddfor analysis. Furthermore, the team needs to ensure that the data are collected in a manner consistent with the sponsor s processes and should also be easy for the site to complete.
11 Recommended Methodologies for Creating Data Collection Instruments CDASH Methodology Employ Standards Within the data collection environment, standards should be employed to collect consistent it tdt data across compounds and TAs. CDASH standards should be used wherever possible and sponsor standards developed as needed. Rationale Using data collection standards across compounds and TAs saves time and money at every step of drugdevelopment. Ui Using standards: d reduces production time for CRF design reduces site re training and queries and p improves compliance and data quality at first collection. enables easy reuse and integration of data across studies and facilitates data mining and the production of integrated summaries. reduces the need for new clinical and statistical programming with each new study.
12 Standard Modules CDISC Special Purpose Domains: Demographics DM Comments CO Interventions: Concomitant Medications CM Exposure EX Substance Use SU Events: Adverse Events AE Disposition DS Medical History MH *Protocol Deviations DV Findings: *Drug Accountability DA ECG Tests EG Inclusion/Exclusion Exceptions IE Laboratory Tests LB *Microbiology MB Questionnaires QS *Pharmacokinetics Concentrations PC *Pharmacokinetics Parameters PP Physical Examinations PE Subject Characteristics SC Vital Signs VS Trial Design Domains: Trial Elements TE Trial Arms TA Trial Visits TV Subject Elements SE Subject Visits SV Trial Inclusion/Exclusion Criteria. TI Trial Summary TS Special Purpose Relationship Datasets: Supplemental Qualifiers SUPPQUAL Relate Records RELREC
13 CREATING A NEW DOMAIN CDISC First, ensure that there is a definite need to create a new domain. Verify that there are no existing domain models Choose the general observation class (Interventions, Events, or Findings) that best fits the data as follows: a. Identify the topic of the observation and determine which of the three general observation classes it most closely resembles. If the new domain shares both the same topicality and general observation class as an existing domain in the submission, the existing domain should be used. b. Look for other existing domain models that may serve as a relevant prototype (most domains will follow the Findings model). c. Determine if the chosen general observation class has most of the required and expected qualifiers for the new domain. d. Select the variables that apply to the new domain once you have selected the general observation class.
14 CDISC creating new variables
15 Analysis datasets Key principles Analysis datasets should: be analysis ready Contain all information needed for analysis results A variety of sources are possible for analysis datasets. One source could be the SDTM datasets submitted as part of a regulatory submission. In all cases, the data sources should be clearly described in the metadata and the analysis dataset creation documentation
16 Analysis datasets Must include a subject level analysis dataset named ADSL consist of the optimum number of analysis datasets needed to allow analysis and review with little or no programming or data processing. maintain SDTM variable attributes if the identical variable also exists in an SDTM dataset. be named using the convention ADxxxxxx. follow naming conventions for datasets dt t and variables ibl that t are sponsor defined and applied consistently across a given submission or multiple submissions for a product, yet use published SDTM naming fragments for variables where feasible.
17 Analysis Data Flow Diagram
18 Programming Standards Creating analysis datasets or standard reports Module macros Performing routine tasks across all modules OR Create variations Component tmacros
19 Governance Develop a standards committee Responsible for approving standards Responsible for adherence to standards Develop support teams SMEs for various roles Programming, Biostatistics Functions domains Creation of standards program/macros Cross functional support
20 Summary Developing standards: Reduce the time and cost of the drug development process by supporting the use of company standards and the sharing/re use of user programs Automate and facilitate company validation efforts Increase drug development knowledge by integrating multiple company data sources Transform data to information Increase knowledge of our drugs
Copyright 2012, SAS Institute Inc. All rights reserved. VISUALIZATION OF STANDARD TLFS FOR CLINICAL TRIAL DATA ANALYSIS
VISUALIZATION OF STANDARD TLFS FOR CLINICAL TRIAL DATA ANALYSIS WENJUN BAO AND JASON CHEN JMP, SAS INC. PHUSE, SHANGHAI, NOV 28, 2014 OUTLINES: CDISC Standard SDTM ADaM Interactive Standardized TLFs Tables
More informationEinführung in die CDISC Standards CDISC Standards around the World. Bron Kisler (CDISC) & Andrea Rauch DVMD Tagung 11.-14.
Einführung in die CDISC Standards CDISC Standards around the World Bron Kisler (CDISC) & Andrea Rauch DVMD Tagung 11.-14. März 2015 1 Outline Overview of CDISC Therapeutic Area Standards SHARE Metadata
More informationPharmaSUG2010 - Paper HS01. CDASH Standards for Medical Device Trials: CRF Analysis. Parag Shiralkar eclinical Solutions, a Division of Eliassen Group
PharmaSUG2010 - Paper HS01 CDASH Standards for Medical Device Trials: CRF Analysis Parag Shiralkar eclinical Solutions, a Division of Eliassen Group Jennie Tedrow Boston Scientific Kit Howard Kestrel Consultants
More informationTraining/Internship Brochure Advanced Clinical SAS Programming Full Time 6 months Program
Training/Internship Brochure Advanced Clinical SAS Programming Full Time 6 months Program Domain Clinical Data Sciences Private Limited 8-2-611/1/2, Road No 11, Banjara Hills, Hyderabad Andhra Pradesh
More informationImplementation of SDTM in a pharma company with complete outsourcing strategy. Annamaria Muraro Helsinn Healthcare Lugano, Switzerland
Italian-Speaking CDISC User Group 2008 Implementation of SDTM in a pharma company with complete outsourcing strategy Annamaria Muraro Helsinn Healthcare Lugano, Switzerland Background Full outsourcing
More informationNote: See 7.7 Representations and Warranties, Limitations of Liability, and Disclaimer.
Clinical Data Acquisition Standards Harmonization (CDASH) Prepared by: CDISC and Domain Teams CDASH_STD-1.0 01/OCT/2008 CDASH V1.0 STANDARD Revision History Document Number Release Date Updates CDASH_STD-1.0
More informationImplementing CDASH Standards Into Data Collection and Database Design. Robert Stemplinger ICON Clinical Research
Implementing CDASH Standards Into Data Collection and Database Design Robert Stemplinger ICON Clinical Research 1 Agenda Reasons for Using CDASH Project Outline Implementation Discussion of Results Reasons
More informationClinical Data Management is involved in all aspects of processing the clinical data, working with a range of computer applications / database systems
Clinical Data Management is involved in all aspects of processing the clinical data, working with a range of computer applications / database systems to support collection, cleaning and management of subject
More informationUSE CDISC SDTM AS A DATA MIDDLE-TIER TO STREAMLINE YOUR SAS INFRASTRUCTURE
USE CDISC SDTM AS A DATA MIDDLE-TIER TO STREAMLINE YOUR SAS INFRASTRUCTURE Kalyani Chilukuri, Clinovo, Sunnyvale CA WUSS 2011 Annual Conference October 2011 TABLE OF CONTENTS 1. ABSTRACT... 3 2. INTRODUCTION...
More informationClinical Data Acquisition Standards Harmonization: Basic Data Collection Fields for Case Report Forms
Clinical Data Acquisition Standards Harmonization: Basic Data Collection Fields for Case Report Forms Prepared by the CDISC CDASH Team Notice to Reviewers This is the CDASH draft posted for public comment.
More informationHow to easily convert clinical data to CDISC SDTM
How to easily convert clinical data to CDISC SDTM Ale Gicqueau, Clinovo, Sunnyvale, CA Miki Huang, Clinovo, Sunnyvale, CA Stephen Chan, Clinovo, Sunnyvale, CA INTRODUCTION Sponsors are receiving clinical
More informationThe CDISC/FDA Integrated Data Pilot: A Case. Support an Integrated Review
The CDISC/FDA Integrated Data Pilot: A Case Studyin Implementing CDISC Standards to Support an Integrated Review d Wise Technologies Chris Decker Life Sciences Director Overview Pilot Mission and Goals
More informationMetadata Submission Guidelines Appendix to the Study Data Tabulation Model Implementation Guide
Metadata Submission Guidelines Appendix to the Study Data Tabulation Model Implementation Guide Prepared by the CDISC SDS Metadata Team Notes to Readers This is Version 0.9 of the Metadata Submissions
More informationWhat is Clinical Data Management
What is Clinical Data Management Clinical Data Management is involved in all aspects of processing the clinical data, working with a range of computer applications, database systems to support collection,
More informationCDISC SDTM & Standard Reporting. One System
CDISC SDTM & Standard Reporting One System 1 Authors/Contributors Merck & Co., Inc. Ram Radhakrishnan, Manager, Statistical Information Systems Thomas W. Dobbins, Ph.D., Executive Director, Biostatistics
More informationABSTRACT INTRODUCTION THE MAPPING FILE GENERAL INFORMATION
An Excel Framework to Convert Clinical Data to CDISC SDTM Leveraging SAS Technology Ale Gicqueau, Clinovo, Sunnyvale, CA Marc Desgrousilliers, Clinovo, Sunnyvale, CA ABSTRACT CDISC SDTM data is the standard
More informationABSTRACT INTRODUCTION PATIENT PROFILES SESUG 2012. Paper PH-07
Paper PH-07 Developing a Complete Picture of Patient Safety in Clinical Trials Richard C. Zink, JMP Life Sciences, SAS Institute, Cary, NC, United States Russell D. Wolfinger, JMP Life Sciences, SAS Institute,
More informationDevelopment of CDISC Tuberculosis Data Standards
Development of CDISC Tuberculosis Data Standards Michael Fiola Senior Director / Quintiles The presenters have disclosed that they have no proprietary or financial interests in the topics covered in this
More informationABSTRACT On October 1st, 2008, CDASH released the first 16 common CRF streams (or domains) for use by the Pharmaceutical Industry.
Paper RS03-2008 A Practical Introduction to Clinical Data Acquisition Standards Harmonization (CDASH) Jennifer Price, Phoenix Data Systems, Inc, King of Prussia, PA ABSTRACT On October 1st, 2008, CDASH
More informationSAS CLINICAL TRAINING
SAS CLINICAL TRAINING Presented By 3S Business Corporation Inc www.3sbc.com Call us at : 281-823-9222 Mail us at : info@3sbc.com Table of Contents S.No TOPICS 1 Introduction to Clinical Trials 2 Introduction
More informationLessons on the Metadata Approach. Dave Iberson- Hurst 9 th April 2014 CDISC Euro Interchange 2014
1 Lessons on the Metadata Approach Dave Iberson- Hurst 9 th April 2014 CDISC Euro Interchange 2014 2 Experience Human beings, who are almost unique in having the ability to learn from the experience of
More informationThe Importance of Good Clinical Data Management and Statistical Programming Practices to Reproducible Research
The Importance of Good Clinical Data Management and Statistical Programming Practices to Reproducible Research Eileen C King, PhD Research Associate Professor, Biostatistics Acting Director, Data Management
More informationA Brief Introduc/on to CDISC SDTM and Data Mapping
A Brief Introduc/on to CDISC SDTM and Data Mapping Agenda Flow of Clinical Trials Data The Problem Introducing CDISC Understanding SDTM Concepts of Data Mapping References 5/3/10 2 Flow of Clinical Trials
More informationSection 1 Project Management, Project Communication/Process Design, Mgmt, Documentation, Definition & Scope /CRO-Sponsor Partnership
Section 1 Project Management, Project Communication/Process Design, Mgmt, Documentation, Definition & Scope /CRO-Sponsor Partnership PROJECT MANAGEMENT - SCOPE DEFINITION AND MANAGEMENT Understands the
More informationOverview of CDISC Implementation at PMDA. Yuki Ando Senior Scientist for Biostatistics Pharmaceuticals and Medical Devices Agency (PMDA)
Overview of CDISC Implementation at PMDA Yuki Ando Senior Scientist for Biostatistics Pharmaceuticals and Medical Devices Agency (PMDA) CDISC 2012 Outline Introduction Update of PMDA activity CDISC implementation
More informationClinical Data Management Overview
The 2 nd Clinical Data Management Training Clinical Data Management Overview Andrew Taylor ( 安 泰 乐 ), M.S. Head of Clinical Data Management August 30, 2010 Learning Objectives Overview of Process Related
More informationNeeds, Providing Solutions
Identifying Needs, Providing Solutions 1 I n d u s t r y The growth of medical research and the countless innovations coming from the pharmaceutical, biotechnology and medical device industry, has improved
More informationCDISC Data Standards Can Facilitate Composition of Adverse Event Narratives
CDISC Data Standards Can Facilitate Composition of Adverse Event Narratives Anisa Scott, Ph.D. and Richard C. Zink, Ph.D. JMP Life Sciences SAS Institute, Inc. anisa.scott@jmp.com Copyright 2010 SAS Institute
More informationPharmaSUG2010 HW06. Insights into ADaM. Matthew Becker, PharmaNet, Cary, NC, United States
PharmaSUG2010 HW06 Insights into ADaM Matthew Becker, PharmaNet, Cary, NC, United States ABSTRACT ADaM (Analysis Dataset Model) is meant to describe the data attributes such as structure, content, and
More informationAnalysis Data Model (ADaM)
Analysis Data Model (ADaM) Prepared by the CDISC Analysis Data Model Team Notes to Readers This is Version 2.1 of the Analysis Data Model (ADaM) Document. It includes modifications so that it corresponds
More informationQUALITY CONTROL AND QUALITY ASSURANCE IN CLINICAL RESEARCH
QUALITY CONTROL AND QUALITY ASSURANCE IN CLINICAL RESEARCH Martin Valania, Executive Director, Corporate QA and Compliance Introduction Pharmaceutical companies recognize the benefits of carefully managing
More informationCDER/CBER s Top 7 CDISC Standards Issues
CDER/CBER s Top 7 CDISC Standards Issues Dhananjay Chhatre, MS, RAC edata Management Solutions Team Office of Business Informatics CDER, U.S. FDA Amy Malla Review Management CBER, U.S. FDA Background ~
More informationBridging Statistical Analysis Plan and ADaM Datasets and Metadata for Submission
, October 24-26, 2012, San Francisco, USA Bridging Statistical Analysis Plan and ADaM Datasets and Metadata for Submission Abstract In this article, the relationship between the Statistical Analysis Plan
More informationRationale and vision for E2E data standards: the need for a MDR
E2E data standards, the need for a new generation of metadata repositories Isabelle de Zegher, PAREXEL Informatics, Belgium Alan Cantrell, PAREXEL, United Kingdom Julie James, PAREXEL Informatics, United
More informationADaM or SDTM? A Comparison of Pooling Strategies for Integrated Analyses in the Age of CDISC
Paper CD01 ADaM or SDTM? A Comparison of Pooling Strategies for Integrated Analyses in the Age of CDISC Joerg Guettner, Bayer Pharma AG, Wuppertal, Germany Alexandru Cuza, UCB Biosciences GmbH, Monheim,
More informationPharmaSUG2010 Paper CD04 CD04
CD04 The CDISC/FDA Integrated Data Pilot: A Final Summary of Findings, Reviewer Feedback, and Recommendations Implementing CDISC Standards Within and Across Studies Chris Decker, d-wise Technologies ABSTRACT
More informationStrategies and Practical Considerations for Creating CDISC SDTM Domain Data Sets from Existing CDM Data Sets
Paper FC05 Strategies and Practical Considerations for Creating CDISC SDTM Domain Data Sets from Existing CDM Data Sets Robert W. Graebner, Quintiles, Inc., Overland Park, KS ABSTRACT Creating CDISC SDTM
More informationIntroduction to the CDISC Standards
Introduction to the CDISC Standards Sandra Minjoe, Accenture Life Sciences, Wayne, Pennsylvania ABSTRACT The Clinical Data Interchange Standards Consortium (CDISC) encompasses a suite of standards across
More informationData Conversion to SDTM: What Sponsors Can Do to Facilitate the Process
Data Conversion to SDTM: What Sponsors Can Do to Facilitate the Process Fred Wood VP, Data Standards Consulting Octagon Research Solutions CDISC U.S. Interchange Baltimore, MD November 2009 1 Outline Background
More informationA white paper presented by: Barry Cohen Director, Clinical Data Strategies Octagon Research Solutions, Inc. Wayne, PA
THE CLINICAL DATA AND REGULATORY EXPERTS SDTM, Plus or Minus A white paper presented by: Barry Cohen Director, Clinical Data Strategies Octagon Research Solutions, Inc. Wayne, PA This Whitepaper is for
More informationSAS Drug Development User Connections Conference 23-24Jan08
SAS Drug Development User Connections Conference 23-24Jan08 Bernd Doetzkies David Ramage Daiichi Sankyo Pharma Development DSPD Clinical Data Repository System Business Drivers System Overview People and
More informationDevelopment of an open metadata schema for Prospective Clinical Research (openpcr)
Supplementary Web Material Development of an open metadata schema for Prospective Clinical Research (openpcr) in China A. Methods We used Singapore Framework for Dublin Core Application Profiles (DCAP),
More informationClinical Data Management (Process and practical guide) Nguyen Thi My Huong, MD. PhD WHO/RHR/SIS
Clinical Data Management (Process and practical guide) Nguyen Thi My Huong, MD. PhD WHO/RHR/SIS Training Course in Sexual and Reproductive Health Research Geneva 2013 OUTLINE Overview of Clinical Data
More informationAutomate Data Integration Processes for Pharmaceutical Data Warehouse
Paper AD01 Automate Data Integration Processes for Pharmaceutical Data Warehouse Sandy Lei, Johnson & Johnson Pharmaceutical Research and Development, L.L.C, Titusville, NJ Kwang-Shi Shu, Johnson & Johnson
More informationWHITE PAPER. CONVERTING SDTM DATA TO ADaM DATA AND CREATING SUBMISSION READY SAFETY TABLES AND LISTINGS. SUCCESSFUL TRIALS THROUGH PROVEN SOLUTIONS
WHITE PAPER CONVERTING SDTM DATA TO ADaM DATA AND CREATING SUBMISSION READY SAFETY TABLES AND LISTINGS. An innovative approach to deliver statistical analysis and data in a CDISC ADaM complient manner
More informationStatistical Operations: The Other Half of Good Statistical Practice
Integrating science, technology and experienced implementation Statistical Operations: The Other Half of Good Statistical Practice Alan Hopkins, Ph.D. Theravance, Inc. Presented at FDA/Industry Statistics
More informationSDTM AND ADaM: HANDS-ON SOLUTIONS
SDTM AND ADaM: HANDS-ON SOLUTIONS CDISC French Speaking User Group Paris, France 17 February 2012 Joris De Bondt, Head Data Standards & Process Improvements Tineke Callant, Senior Biostatistical Analyst
More informationData Management: Good Team Work is de sleutel tot succes!
Data Management: Good Team Work is de sleutel tot succes! Gerald Ruiter Senior Data Manager Topics Introduction Data Management Activities People Process Technology Clinical Data Management: introduction
More informationPK IN DRUG DEVELOPMENT. CDISC management of PK data. Matteo Rossini Milan, 9 February 2010
Matteo Rossini Milan, 9 February 2010 Introduction to CDISC CDISC: Clinical Data Interchange Standards Consortium CDISC is a global, open, multidisciplinary, non-profit organization that has established
More informationData-centric System Development Life Cycle for Automated Clinical Data Development System Kevin Lee, MarkLogic, Washington D.C.
Data-centric System Development Life Cycle for Automated Clinical Data Development System Kevin Lee, MarkLogic, Washington D.C. ABSTRACT Many life science organizations have been building systems to automate
More informationChallenges and Opportunities in Clinical Trial Data Processing
Challenges and Opportunities in Clinical Trial Data Processing Vadim Tantsyura, Olive Yuan, Ph.D. Sergiy Sirichenko (Regeneron Pharmaceuticals, Inc., Tarrytown, NY) PG 225 Introduction The review and approval
More informationAnalysis Data Model: Version 2.0
1 2 Analysis Data Model: Version 2.0 Prepared by the CDISC Analysis Dataset Modeling Team (ADaM) Notes to Readers This Model incorporates aspects of the previous General Considerations document version
More informationSTUDY DATA TECHNICAL CONFORMANCE GUIDE
STUDY DATA TECHNICAL CONFORMANCE GUIDE Technical Specifications Document This Document is incorporated by reference into the following Guidance Document(s): Guidance for Industry Providing Regulatory Submissions
More informationProgramme Guide PGDCDM
Post Graduate Diploma in Clinical Data Management and Biostatistics with SAS Programme Guide PGDCDM School of Health Sciences Indira Gandhi National Open University WHY THIS PROGRAMME? The Post Graduate
More informationUsing SAS Data Integration Studio to Convert Clinical Trials Data to the CDISC SDTM Standard Barry R. Cohen, Octagon Research Solutions, Wayne, PA
Using SAS Data Integration Studio to Convert Clinical Trials Data to the CDISC SDTM Standard Barry R. Cohen, Octagon Research Solutions, Wayne, PA ABSTRACT A new industry standard for clinical trials data,
More informationClinical Data Management (Process and practical guide) Dr Nguyen Thi My Huong WHO/RHR/RCP/SIS
Clinical Data Management (Process and practical guide) Dr Nguyen Thi My Huong WHO/RHR/RCP/SIS Training Course in Sexual and Reproductive Health Research Geneva 2012 OUTLINE Clinical Data Management CDM
More informationPhUSE 2015. Paper CD07. Data Governance Keeping Control through a Well-Defined Change Request Process
PhUSE 2015 Paper CD07 Data Governance Keeping Control through a Well-Defined Change Request Process Author: Gavin Winpenny, Business & Decision Life Sciences, Brussels, Belgium Introduction The effective
More informationOptimally Scheduling Resource Constraint Project Using SAS/OR Jeff Cai, Amgen Inc., Thousand Oaks, CA
Optimally Scheduling Resource Constraint Project Using SAS/OR Jeff Cai, Amgen Inc., Thousand Oaks, CA ABSTRACT This paper shares with SAS users an approach to effectively distribute programming resources
More informationImplementing the CDISC standards into an existing CDMS
Implementing the CDISC standards into an existing CDMS Presented by Ueng-Cheng Yang (yang@ym.edu.tw) Institute of Biomedical Informatics National Yang-Ming University 1 TCT is a resource center to support
More informationBRIDGing CDASH to SAS: How Harmonizing Clinical Trial and Healthcare Standards May Impact SAS Users Clinton W. Brownley, Cupertino, CA
BRIDGing CDASH to SAS: How Harmonizing Clinical Trial and Healthcare Standards May Impact SAS Users Clinton W. Brownley, Cupertino, CA ABSTRACT The Clinical Data Interchange Standards Consortium (CDISC),
More informationSTUDY DATA TECHNICAL CONFORMANCE GUIDE
STUDY DATA TECHNICAL CONFORMANCE GUIDE Technical Specifications Document This Document is incorporated by reference into the following Guidance Document(s): Guidance for Industry Providing Regulatory Submissions
More informationCDISC Roadmap Outline: Further development and convergence of SDTM, ODM & Co
CDISC Roadmap Outline: Further development and convergence of SDTM, ODM & Co CDISC Ausblick: Weitere Entwicklung und Konvergenz der CDISC-Standards SDTM, ODM & Co. Jozef Aerts - XML4Pharma Disclaimer Views
More informationCREATING SV AND SE FIRST Henry B. Winsor, WinsorWorks, Limited, San Mateo, CA Mario Widel, Genentech, Inc., South San Francisco, CA
ABSTRACT PharmaSUG2010 - Paper CD09 CREATING SV AND SE FIRST Henry B. Winsor, WinsorWorks, Limited, San Mateo, CA Mario Widel, Genentech, Inc., South San Francisco, CA One current concern of the FDA is
More informationThe Development of the Clinical Trial Ontology to standardize dissemination of clinical trial data. Ravi Shankar
The Development of the Clinical Trial Ontology to standardize dissemination of clinical trial data Ravi Shankar Open access to clinical trials data advances open science Broad open access to entire clinical
More informationSTANDARD OPERATING PROCEDURE NO. CM.13-00 - 00
STANDARD OPERATING PROCEDURE NO. CM.13-00 - 00 Version date: Effective Date: Replaces SOP No.: 1 5 January 20 13 15 February 20 13 Approved by: Date No: CM.13 00 00 Effective Date: 15 February 2013 Version
More informationProjectTrackIt: Automate your project using SAS
Paper PP09 ProjectTrackIt: Automate your project using SAS Abhishek Bakshi, Cytel, Pune, India ABSTRACT Entering information in a project programming tracker is one of the menial tasks taking up time which
More informationSynergizing global best practices in the CRO industry
Synergizing global best practices in the CRO industry KREARA - India Established on April 24 th 2004 Contract Research Services to Pharmaceutical companies Clinical Data management and Biometrics Interactive
More informationBusiness & Decision Life Sciences CDISC Workshop: From SDTM to ADaM: Mapping Methodologies
Business & Decision Life Sciences CDISC Workshop: From SDTM to ADaM: Mapping Methodologies Jessica Minkue Mi Edou / 18th September 2014 From SDTM to ADaM: Mapping Methodologies CDISC and ADaM Introduc0on
More informationPhUSE 2010. Paper CD13
Paper CD13 Clinical Data Interchange Standards Consortium (CDISC) integration into the Oracle Clinical/Remote Data Capture (OC/RDC) clinical data management system Peter Van Reusel, Business & Decision
More informationHow to build ADaM from SDTM: A real case study
PharmaSUG2010 - Paper CD06 How to build ADaM from SDTM: A real case study JIAN HUA (DANIEL) HUANG, FOREST LABORATORIES, NJ ABSTRACT: Building analysis data based on the ADaM model is highly recommended
More informationCDISC SDTM/ADaM Pilot Project 1 Project Report
Executive Summary Background CDISC SDTM/ADaM Pilot Project 1 Project Report CDISC is a non-profit, multidisciplinary consensus based standards development organization founded over a decade ago that has
More informationFrom Validating Clinical Trial Data Reporting with SAS. Full book available for purchase here.
From Validating Clinical Trial Data Reporting with SAS. Full book available for purchase here. Contents Preface ix Acknowledgments xi Chapter 1 Pharmaceutical Industry Overview 1 1.1 Introduction 2 1.2
More informationData Quality in Clinical Trials: a Sponsor's view
Data Quality in Clinical Trials: a Sponsor's view Elena Carzana Data Manager Chiesi Farmaceutici Padova, 27 th September 2012 IV BIAS ANNUAL CONGRESS Data Quality in Clinical Trials Agenda Definition Impacts
More informationKCR Data Management: Designed for Full Data Transparency
KCR Data Management: Designed for Full Data Transparency 6% Observational 4% Phase IV 2% Device 11% Phase I 28% Phase II 49% Phase III The quality of study data relies first and foremost on the quality
More informationUnderstanding CDISC Basics
Trends in Bio/Pharmaceutical Industry Understanding CDISC Basics Jane Ma Abstract Data standards can make data and its associated program more portable. The CDISC (Clinical Data Interchange Standards Consortium)
More informationJanus Clinical Trials Repository (CTR) An Update
Janus Clinical Trials Repository (CTR) An Update Armando Oliva, M.D. Associate Director for Informatics CDER Office of Computational Science U.S. Food and Drug Administration 2015-03-16 The views expressed
More informationSpeed to Market Abbott Nutrition Experience in Streamlining the Pediatric Clinical Research Process
Speed to Market Abbott Nutrition Experience in Streamlining the Pediatric Clinical Research Process Geraldine Baggs, Suzanne Monnin, Deborah Shye, Sue Zhang Abbott Nutrition Research & Development Abbott
More informationPractical application of SAS Clinical Data Integration Server for conversion to SDTM data
Paper DM03 Practical application of SAS Clinical Data Integration Server for conversion to SDTM data Peter Van Reusel, Business & Decision Life Sciences, Brussels, Belgium Mark Lambrecht, SAS, Tervuren,
More informationOrganization Profile. IT Services
Introduction In today s scientific and medical world, various issues in clinical trials and research have permeated every society and every field in medicine. Ethics and in particular the quality of research
More informationThe ADaM Solutions to Non-endpoints Analyses
The ADaM Solutions to Non-endpoints Analyses ABSTRACT Chengxin Li, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA There always exist some analyses for non endpoints in the study. These
More informationLessons Learned from the QC Process in Outsourcing Model Faye Yeh, Takeda Development Center Americas, Inc., Deerfield, IL
ABSTRACT PharmaSUG 2015 Paper TT11 Lessons Learned from the QC Process in Outsourcing Model Faye Yeh, Takeda Development Center Americas, Inc., Deerfield, IL As more and more companies in the pharmaceutical
More informationThe CDISC Study Data Tabulation Model (SDTM): History, Perspective, and Basics Fred Wood Principal Consultant, Octagon Research Solutions
Paper RS10 The CDISC Study Data Tabulation Model (SDTM): History, Perspective, and Basics Fred Wood Principal Consultant, Octagon Research Solutions ABSTRACT The CDISC (Clinical Data Interchange Standards
More informationPharmaceutical Applications
Integrated Summary of Safety and Efficacy Programming for Studies Using Electronic Data Capture Changhong Shi, Merck & Co., Inc., Rahway, NJ Qing Xue, Merck & Co., Inc., Rahway, NJ ABSTRACT The Integrated
More informationPharmaSUG 2015 - Paper DS02
PharmaSUG 05 - Paper DS0 SDTM TE, T, and SE Domains: Demystifying the Development of SE Kristin Kelly, ccenture ccelerated R&D Services, erwyn, P Fred Wood, ccenture ccelerated R&D Services, erwyn, P Jerry
More informationSunday, May 15, 2011 1:00 PM 5:00 PM Georgia B
Society for Clinical Trials 32 nd Annual Meeting Workshop P10 The Essentials of Clinical Data Management Sunday, May 15, 2011 1:00 PM 5:00 PM Georgia B 2011 Society for Clinical Trials Pre-Conference Workshop
More informationTrials and Tribulations of SDTM Trial Design
PharmaSUG 2011 - Paper CD13 Trials and Tribulations of SDTM Trial Design Fred Wood, Octagon Research Solutions, Wayne, PA Mary Lenzen, Octagon Research Solutions, Wayne, PA ABSTRACT An increasing number
More informationCDISC standards and data management The essential elements for Advanced Review with Electronic Data
Session 6: Toward Electronic Submission of Study Data for New Drug Applications CDISC standards and data management The essential elements for Advanced Review with Electronic Data Yuki Ando Senior Scientist
More informationInfoset builds software and services to advantage business operations and improve patient s life
Infoset builds software and services to advantage business operations and improve patient s life Clinical Data Management ecrf & EDC Patient Support Programs Medication Adherence Mobile e-health Big Data
More informationBusiness & Decision Life Sciences What s new in ADaM
Business & Decision Life Sciences What s new in ADaM Gavin Winpenny 23 rd June 2015 Agenda What s happening CDISC and Regulatory Submission Landscape ADaM Implementation Guide ADaM Data Structures for
More informationADaM Implications from the CDER Data Standards Common Issues and SDTM Amendment 1 Documents Sandra Minjoe, Octagon Research Solutions, Wayne, PA
ABSTRACT: ADaM Implications from the CDER Data Standards Common Issues and SDTM Amendment 1 Documents Sandra Minjoe, Octagon Research Solutions, Wayne, PA Over the past few years, the United States Food
More informationThe REUSE project: EHR as single datasource for biomedical research
The REUSE project: EHR as single datasource for biomedical research Naji El Fadly 1,3, Noël Lucas 2, Pierre-Yves Lastic 4, François Macary 5, Philippe Verplancke 6, Christel Daniel 1,2 1 INSERM UMRS 872,
More informationTherapeutic Area Standards (TAS) Initiative Project Plan
Therapeutic Area Standards (TAS) Initiative Project Plan Version: 2.0 Document Date: June, 2014 REVISION HISTORY Version Number Revision Date Description of Change 1.0 September, 2013 Initial Document
More information11. Extension Potential Financial Benefits
11. Extension Potential Financial Benefits Estimating the financial value of using electronic health records (EHR) for clinical research is fraught with difficulties for a number of reasons, some of which
More informationAbstract TUTORIAL 1 CDISC STANDARDS : DETAILING THE DATA. Disclaimer
TUTORIAL 1 CDISC STANDARDS : DETAILING THE DATA Co-Instructors Pierre-Yves Lastic, Senior Director, Data Privacy & Healthcare Interoperability Standards, sanofi, France & CDISC Board Member Stephen E.
More informationPharmaSUG 2016 Paper IB10
ABSTRACT PharmaSUG 2016 Paper IB10 Moving from Data Collection to Data Visualization and Analytics: Leveraging CDISC SDTM Standards to Support Data Marts Steve Kirby, JD, MS, Chiltern, King of Prussia,
More informationSAS Clinical Interview QUESTIONS and ANSWERS
SAS Clinical Interview QUESTIONS and ANSWERS What is the therapeutic area you worked earlier? There are so many diff. therapeutic areas a pharmaceutical company can work on and few of them include, anti-viral
More informationUsing the SAS XML Mapper and ODS PDF to create a PDF representation of the define.xml (that can be printed)
Using the SAS XML Mapper and ODS PDF to create a PDF representation of the define.xml (that can be printed) Lex Jansen TAKE Solutions CDISC Atlantic User Group Meeting 2008-02-21 Regulatory Landscape (FDA)
More informationThe role, duties and responsibilities of clinical trials personnel Monitoring: rules and recommendations
The role, duties and responsibilities of clinical trials personnel Monitoring: rules and recommendations Maria Luisa Paoloni OPBG Clinical & Research Services Monitoring and Responsible of monitoring:
More informationElectronic Submission of Regulatory Information, and Creating an Electronic Platform for Enhanced Information Management
Written Notice of Participation by the Clinical Data Interchange Standards Consortium (CDISC) and Written Statement for Discussion Topics to be Addressed In the FDA Public Hearing: Electronic Submission
More informationEffective Data Management Plans for Research Studies Patrick Murphy, Research Informatics, Family Health International
Effective Data Management Plans for Research Studies Patrick Murphy,, Family Health International 1 What is a Data Management Plan? A document that describes how data (clinical, behavioural, lab) will
More information